Nectar Lifesciences Income Tax Litigation Concluded Favorably

Nectar Lifesciences discloses favorable conclusion of income tax litigation for AY 2017-18 via DCIT order dated March 31, 2026.
The matter involved writ petitions challenging reassessment notices for AY 2017-18 to 2021-22, with previous favorable orders for AY 2018-19 to 2021-22.
Company confirms nil financial implication from the concluded litigation and attributes disclosure delay to former employee email inaccessibility.